Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-001739·STROME MARK E
Schedule 13D ownership disclosure
ZIVO BIOSCIENCE
Common Stock, par value $.001 per share · CUSIP: 98978N101
Event date: 2024-12-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mark E. StromeReported CIK 0000919484
Shares: 442,854.00 · Class: 12.20%
- Strome Group, Inc.
Shares: 222,505.00 · Class: 6.13%
- Strome Investment Management, LP
Shares: 222,505.00 · Class: 6.13%
- Strome Mezzanine Fund, LPReported CIK 0001713153
Shares: 45,064.00 · Class: 1.24%
- Strome Mezzanine Fund II, LP
Shares: 165,000.00 · Class: 4.55%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-001739
- Form type
- SCHEDULE 13D/A
- Filer
- STROME MARK E
- CIK
- CIK 919484
- Filed
- Jan 07, 2025
- Reporting period
- Dec 26, 2024
- Description
- Schedule 13D beneficial ownership